Showing results (591-600 of 1,191) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|December 6, 2011
An assessment of the statistical methods used to analyse toxicology studiesPhilip Jarvis, Jim Saul, Mike Aylott, et al.Pharmaceutical Statistics|December 1, 2011
Opportunities for minimization of confounding in observational researchGeorge Quartey, Maurille Feudjo-Tepie, Jixian Wang, et al.Pharmaceutical Statistics|September 30, 2011
Adjusting for covariates in non-inferiority studies with margins defined as risk differencesKhadeeja Mohamed, Andrew Embleton, Robert L CuffePharmaceutical Statistics|December 14, 2011
A statistician's perspective on biomarkers in drug developmentMartin Jenkins, Aiden Flynn, Trevor Smart, et al.Pharmaceutical Statistics|September 20, 2011
The ABC of non-inferiority margin setting from indirect comparisonsSteven A JuliousPharmaceutical Statistics|May 2, 2009
Impact of missing data on type 1 error rates in non-inferiority trialsBongin YooPharmaceutical Statistics|June 11, 2009
Empirical Bayes models of Poisson clinical trials and sample size determinationBoris G ZaslavskyPharmaceutical Statistics|January 4, 2012
Statistical approaches for conducting network meta-analysis in drug developmentByron Jones, James Roger, Peter W Lane, et al.Pharmaceutical Statistics|February 17, 2012
Parallel, AA/BB, AB/BA and Balaam's design: efficient and maximin choices when testing the treatment effect in a mixed effects linear regressionMath J J M CandelPharmaceutical Statistics|March 8, 2012
Expected loss functions as additional measures to assess performance of multiple testing procedures for combination drug dose findingJulia N Soulakova, Allan R SampsonPageof 120